Developers of biosimilars -- medicines that are near-identical copies of biologic drugs -- will no longer be required to conduct clinical trials to prove effectiveness.
Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy ...
October 2025 proved to be a significant month for the oncology landscape, marked by a wave of key regulatory decisions from the US FDA. This period saw important full and accelerated drug approvals ...
More than 580,000 bottles of a popular blood pressure medication distributed nationwide have been recalled, according to the U.S. Food and Drug Administration. The recall involves bottles of Prazosin ...
According to the FDA, the Centers for Disease Control and Prevention's case count for illnesses tied to the listeria outbreak has increased, with seven reports of new illnesses across three states, ...
Teva Pharmaceuticals USA and drug distributor Amerisource Health Services has recalled more than half a million bottles of a ...
Over half a million bottles of prazosin hydrochloride have been recalled for having high levels of potentially cancer-causing ...
Blood pressure medication was recalled by the FDA. The prescription drug didn’t meet the agency’s standards for a lack of ...
Additional ground cinnamon products were the subject of an Oct. 30 recall notice from the FDA. Affected products contained ...
Numerous recalls have been initiated this year because of the potential for damaged products, foodborne illness and ...
The U.S. Food and Drug Administration recalled more than 140,000 bottles of a common statin medication. Is your medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback